• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短链脂肪酸、胰腺功能障碍与 2 型糖尿病。

Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes.

机构信息

Institute of Science, Nirma University, Ahmedabad, Gujarat, 382481, India.

出版信息

Pancreatology. 2019 Mar;19(2):280-284. doi: 10.1016/j.pan.2019.01.021. Epub 2019 Jan 28.

DOI:10.1016/j.pan.2019.01.021
PMID:30713129
Abstract

The microbiota living in gut influence the immune response, metabolism, mood and behavior. The diet plays a pivotal role in maintaining healthy gut microbiota composition and its fermentation leads to production of Short Chain Fatty Acids (SCFAs) mainly acetate, propionate and butyrate. During pancreatic dysfunction, insulin mediated suppression of glucagon is impaired leading to uncontrolled glucose production by liver and state of hyperglycemia. Insulin and glucagon balance is as important as insulin sensitivity which is reduced during Type 2 Diabetes (T2D). Glucagon like peptide-1 (GLP1) produced by Intestinal epithelial cells regulates insulin and glucagon secretion directly via GLP1 receptor on pancreatic cells or via nervous system. But half-life period of GLP1 is very short i.e. about 2 min, after which it is cleaved and inactivated. SCFAs are well documented to induce GLP1 but its direct effect on pancreatic dysfunction has not been reported. This review opens a new avenue to study the role of SCFAs as treatment to pancreatic dysfunction and T2D.

摘要

肠道中的微生物群会影响免疫反应、代谢、情绪和行为。饮食在维持健康的肠道微生物群组成方面起着关键作用,其发酵会导致短链脂肪酸(SCFAs)的产生,主要是乙酸盐、丙酸盐和丁酸盐。在胰腺功能障碍时,胰岛素介导的胰高血糖素抑制作用受损,导致肝脏不受控制地产生葡萄糖,从而出现高血糖状态。胰岛素和胰高血糖素的平衡与胰岛素敏感性同样重要,而在 2 型糖尿病(T2D)中,胰岛素敏感性会降低。肠上皮细胞产生的胰高血糖素样肽-1(GLP1)通过胰腺细胞上的 GLP1 受体或通过神经系统直接调节胰岛素和胰高血糖素的分泌。但 GLP1 的半衰期非常短,约为 2 分钟,之后会被切割并失活。已有充分的证据表明 SCFAs 可诱导 GLP1,但尚未有报道其对胰腺功能障碍的直接作用。本综述为研究 SCFAs 作为治疗胰腺功能障碍和 T2D 的作用开辟了新途径。

相似文献

1
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes.短链脂肪酸、胰腺功能障碍与 2 型糖尿病。
Pancreatology. 2019 Mar;19(2):280-284. doi: 10.1016/j.pan.2019.01.021. Epub 2019 Jan 28.
2
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).肠道微生物群衍生的短链脂肪酸(SCFAs)的免疫调节潜力。
Acta Biochim Pol. 2019 Mar 4;66(1):1-12. doi: 10.18388/abp.2018_2648.
3
Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.青钱柳叶多糖通过调节肠道微生物群和短链脂肪酸来缓解 2 型糖尿病症状。
Phytomedicine. 2020 Oct;77:153268. doi: 10.1016/j.phymed.2020.153268. Epub 2020 Jun 30.
4
Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.2 型糖尿病患者循环中的短链脂肪酸和胆汁酸水平升高与肠道屏障破坏和肠道微生物群落紊乱有关。
Diabetes Res Clin Pract. 2020 Nov;169:108418. doi: 10.1016/j.diabres.2020.108418. Epub 2020 Sep 4.
5
Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice.短链脂肪酸与小鼠胰腺内分泌分泌的调节。
Islets. 2019;11(5):103-111. doi: 10.1080/19382014.2019.1587976. Epub 2019 Aug 30.
6
The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids.膳食纤维与肠道微生物群的相互作用通过产生短链脂肪酸影响2型糖尿病。
Foods. 2023 Feb 28;12(5):1023. doi: 10.3390/foods12051023.
7
Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.益生菌和丁酸产生菌丰富的微生物组通过产生短链脂肪酸和分泌激素来管理便秘。
Mol Nutr Food Res. 2019 Dec;63(23):e1801187. doi: 10.1002/mnfr.201801187. Epub 2019 Oct 22.
8
Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion.肠道微生物群衍生的短链脂肪酸(SCFAs)在胰腺 β 细胞生长和胰岛素分泌中的争议性作用。
Int J Mol Sci. 2020 Jan 30;21(3):910. doi: 10.3390/ijms21030910.
9
[Changes in the synthesis of short-chain fatty acids under the influence of various factors in healthy people and patients with type 2 diabetes mellitus].[健康人和2型糖尿病患者在各种因素影响下短链脂肪酸合成的变化]
Vopr Pitan. 2024;93(1):33-43. doi: 10.33029/0042-8833-2024-93-1-33-43. Epub 2023 Dec 26.
10
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.肠道微生物群短链脂肪酸作为改善糖尿病的关键病理生理分子的证据。
Mediators Inflamm. 2014;2014:162021. doi: 10.1155/2014/162021. Epub 2014 Aug 17.

引用本文的文献

1
The Impact of Ramadan Fasting on Endothelial Function, Cardiovascular Risk Factors, and Cardiovascular Disease.斋月禁食对内皮功能、心血管危险因素和心血管疾病的影响。
J Clin Med. 2025 Sep 2;14(17):6191. doi: 10.3390/jcm14176191.
2
The Antidiabetic Mechanisms of Cinnamon Extract: Insights from Network Pharmacology, Gut Microbiota, and Metabolites.肉桂提取物的抗糖尿病机制:来自网络药理学、肠道微生物群和代谢物的见解
Curr Issues Mol Biol. 2025 Jul 12;47(7):543. doi: 10.3390/cimb47070543.
3
Does Gut Microbial Methylglyoxal Metabolism Impact Human Physiology?
肠道微生物甲基乙二醛代谢会影响人体生理机能吗?
Antioxidants (Basel). 2025 Jun 21;14(7):763. doi: 10.3390/antiox14070763.
4
Gut microbiota-derived SCFAs and MetS-related nephropathy.肠道微生物群衍生的短链脂肪酸与代谢综合征相关肾病
Front Nutr. 2025 Jul 8;12:1561271. doi: 10.3389/fnut.2025.1561271. eCollection 2025.
5
Circulating short chain fatty acid levels and body composition in type 2 diabetes mellitus.2型糖尿病患者的循环短链脂肪酸水平与身体组成
Int J Med Sci. 2025 Apr 22;22(10):2289-2297. doi: 10.7150/ijms.111920. eCollection 2025.
6
Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies.肠道微生物群代谢产物与慢性疾病:相互作用、机制及治疗策略
Int J Mol Sci. 2025 Apr 16;26(8):3752. doi: 10.3390/ijms26083752.
7
Dose-Dependent Effects of Short-Chain Fatty Acids on 3T3-L1 Adipocyte Adipokine Secretion and Metabolic Function.短链脂肪酸对3T3-L1脂肪细胞脂肪因子分泌和代谢功能的剂量依赖性影响
Nutrients. 2025 Feb 4;17(3):571. doi: 10.3390/nu17030571.
8
Ganoderic Acid A Alleviates Severe Acute Pancreatitis by Modulating Gut Homeostasis and Inhibiting TLR4-NLRP3 Signaling.灵芝酸A通过调节肠道稳态和抑制TLR4-NLRP3信号通路减轻重症急性胰腺炎。
J Agric Food Chem. 2025 Jan 15;73(2):1563-1579. doi: 10.1021/acs.jafc.4c07635. Epub 2024 Dec 31.
9
Gut Microbiota and Diabetes: Pioneering New Treatment Frontiers.肠道微生物群与糖尿病:开拓新的治疗前沿。
Endocr Metab Immune Disord Drug Targets. 2025 Jan 8. doi: 10.2174/0118715303342579241119155225.
10
Assessment of Immobilized OLXAL-1 Cells on Oat Flakes for Functional Regulation of the Intestinal Microbiome in a Type-1 Diabetic Animal Model.在1型糖尿病动物模型中,评估燕麦片上固定化的OLXAL-1细胞对肠道微生物群的功能调节作用。
Foods. 2024 Dec 20;13(24):4134. doi: 10.3390/foods13244134.